Bluejay Diagnostics, Inc.
SEC CIK 1704287 · BJDX · last insider filing 2026-05-18
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Chase Donald R | Director | filed 2021 - 2026 |
| Wurth Douglas Clark | Director | filed 2021 - 2026 |
| Dey Svetlana | Director | filed 2021 - 2026 |
| Dey Indranil | Director · President and CEO | filed 2021 - 2026 |
| Zeidman Fred S | Director | filed 2021 - 2026 |
| Gemignani Gary G | Director | filed 2021 - 2023 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Scally Frances P | CFO | filed 2023 - 2023 |
| Cook Jason | Chief Technology Officer | filed 2023 - 2023 |
| Fisher Kenneth R | Chief Financial Officer | filed 2022 - 2023 |
| Kinder Gordon Winston | Chief Financial Officer | filed 2021 - 2022 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.